Sun Pharma: Full Form, Profile, Latest Revenue and Financials Details

Company profile is the section where you can have a brief description about well established and financially sound companies that are listed in the Indian Stock Exchanges. This section will provide a keen overview about the company in terms of its origin, founders, latest financial reports and much more. We will try to make this article as informative as possible so that virtually this page becomes the Sun Pharma Wiki for a stock market beginner.Sun Pharma Full FormThis week we would be exploring Sun Pharma who is one of the highly reputed multinational pharmaceutical company which primarily operates in India and United States.Companies Origin & Profile:Brief Company Profile:Sun Pharma Industries was established in the year 1983 in Vapi, Gujarat Within the 2 years span it has extended its sales throughout nation. Subsequently the company has launched cardiology drugs in the year 1987 accompanied by gastroenterology drugs in the year 1989. With global revenues of US$ 4.5 billion, Sun Pharma is the fifth largest specialty generic pharmaceutical company in the world. Mainly markets outside India contributes to over 72% of Sun Pharma sales US is the sole gigantic market, considering about 50% business; in all, 93% of turnover is captured by finished dosage forms and formulations.Inception & Founders: Sun Pharma Industries was incorporated by Mr Dilip Shanghvi. Starting with five products that were used to cure psychiatry ailments.Chairman & Directors:Mr Israel Makov is the Chairman and Mr Dilip Shanghvi is the managing director of Sun Pharma Industries Limited.Customer Segment & Area of Operations:Sun Pharma has a diverse and highly independent portfolio of speciality and generic products focusing on a vast range of acute and chronic treatments. Its products cover the full range of ointments, capsules, tablets, liquids and creams. The remedical segments consists of more than 2000 high quality molecules which consists of neurology, urology, gastroenterology, diabetology, dental and nutritionals among others. Besides this it also capable of manufacturing Active Pharmaceutical Ingredients(APIs), anti- retrovirals(ARV’s) and over-the-counter(OTC) among others.Confidence Booster for Investors:The following pointers will uplift the confidence of any stock market analyst. As this highlight the favourable business outcomes for Sun Pharma.
  • Sales growth for the past 3 years has been at 25.22 %.
  • Having highest market cap in the pharma industry at Rs 140564.43 Cr.
  • The compounded profit growth of the past 5 years at been at 23.02%.
Quick Financial Information(Last Updated on 02/08/2018):Following table highlights Key ratios and financial variables which will help investors a lot.
Particulars Info
Current Price:585.85
52 weeks High / Low608.55 / 433.15
Market Cap:140,564 Cr.
Stock P/E:41.38
Face Value1
ROCE:21.01 %
Book Value:163.58
Dividend Yield:0.60 %
Sales Growth (3Yrs):25.22 %
Listed onBSE and NSE
ROE:19.86 %
Shareholding pattern:The table below highlights the approximate shareholding pattern of Sun Pharma.
Holder's Name% Shareholding
Foreign Institutions16.40%
Banks and Mutual Funds8.41%
Financial Institutions8.17%
General Public6.97%
Peer Comparison:The table below highlights the Top 7 companies in the same business, therefore, giving the easy benchmark for comparing Sun Pharma with other 6 companies in the same business.
S.No.NameCMP Rs.P/EMar Cap Rs.Cr.Div Yld %NP Qtr Rs.Cr.Qtr Profit Var %Sales Qtr Rs.Cr.Qtr Sales Var %ROCE %
1Piramal Enterp.2,7941050,4651-69.81-33.362902.4929.2428.33
2Sun Pharma.Inds.58641140,56411528.9910.356977.1-2.2421.01
3Unichem Labs.236.40.661662.912.11-20.65-1476.67201.4342.54-15.38
4Aurobindo Pharma623.1515.0736510.830.4528.51-0.744049.0911.1927.6
5Cadila Health.377.321.7538625.810.93590.853.263250.231.7721.04
7Claris Lifescien396.551.372163.880.5-317.43-1809.372.07-54.51-10.91
Annual & Quarterly Results: Below is the Quarterly Results of Sun Pharma
Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016
Operating Profit1,6831,4531,3751451,5472,453
OPM %24.13%21.84%20.68%2.34%21.68%30.95%
Other Income302129254151224122
Profit before tax1,3751,1471,114-1581,3882,102
Net Profit1,5284001,001-3221,3851,721
Annual Results of Sun Pharma
Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012
Operating Profit10,0897,4737,6284,4824,3063,203
OPM %31.95%26.23%27.85%27.87%38.69%39.94%
Other Income623658547552388471
Profit before tax9,0476,5706,4024,5814,3143,355
Net Profit6,9644,5454,5393,1412,9832,656
Cash Flow statement:Readers will find the cash flow statements of Sun Pharma of past 6 years.
Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012
Cash from Operating Activity7,0826,6855,6153,9593,3562,234
Cash from Investing Activity-4,186-3,949-1,502-2,176-2,375-747
Cash from Financing Activity-2,285-1,888-1,186506-664-544
Net Cash Flow6108482,9262,289316942
Balance Sheet: The below table highlights the balance sheet position of Sun Pharma for the past 6 years.
Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012
Share Capital239240207207103103
Other Liabilities15,44014,46314,6358,2985,3433,945
Total Liabilities61,91155,94149,21729,38420,59216,502
Fixed Assets17,67515,87212,6826,8175,6473,951
Other Assets40,24336,06431,78018,93911,9719,993
Total Assets61,91155,94149,21729,38420,59216,502
For more useful articles on trading, investing and market knowledge, visit our Knowledge Center section.(Note: The above list is for information purpose only. Avoid trading and investing based on the information given above. Before investing in stocks do due diligence).

Download App to know your Andekha Sach

Get the link to download the app.

Google Play Store App Store
Samco Fast Trading App

About The Author

Leave A Comment?